475
Participants
Start Date
June 15, 2020
Primary Completion Date
February 7, 2022
Study Completion Date
April 12, 2022
Enoxaparin 40Mg/0.4Ml Inj Syringe 0.4Ml
daily incetion s.c. for 14 days
University Hospital Basel, Basel
University Hospital Zurich, Zurich
Johannes Gutenberg-Universität Mainz, Mainz
Universitätsklinikum Freiburg, Freiburg im Breisgau
Clinic of Hematology, Oncology Institute of Southern Switzerland, Bellinzona
University Hospital Bern, Bern
Hôpitaux Universitaires Genève, Geneva
Clinica Luganese Moncucco, Lugano
Collaborators (1)
Insel Gruppe AG, University Hospital Bern
OTHER
University Hospital, Geneva
OTHER
Centre Hospitalier Universitaire Vaudois
OTHER
University Hospital, Basel, Switzerland
OTHER
Oncology Institute of Southern Switzerland
OTHER
Clinica Luganese Moncucco
OTHER
University Hospital Freiburg
OTHER
Mainz University
OTHER
University of Zurich
OTHER